Your browser doesn't support javascript.
loading
Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?
Synnott, N C; Murray, A; McGowan, P M; Kiely, M; Kiely, P A; O'Donovan, N; O'Connor, D P; Gallagher, W M; Crown, J; Duffy, M J.
Afiliação
  • Synnott NC; UCD School of Medicine and Medical Science, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
  • Murray A; UCD School of Medicine and Medical Science, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
  • McGowan PM; UCD School of Medicine and Medical Science, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
  • Kiely M; Department of Life Sciences, University of Limerick, Limerick, Ireland.
  • Kiely PA; Department of Life Sciences, University of Limerick, Limerick, Ireland.
  • O'Donovan N; National Institute for Cellular Biotechnology (NICB), Dublin City University, Dublin, Ireland.
  • O'Connor DP; Department of Molecular & Cellular Therapeutics, Royal College of Surgeons Ireland, Dublin, Ireland.
  • Gallagher WM; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
  • Crown J; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.
  • Duffy MJ; UCD School of Medicine and Medical Science, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
Int J Cancer ; 140(1): 234-246, 2017 Jan 01.
Article em En | MEDLINE | ID: mdl-27615392

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinuclidinas / Compostos Aza / Proteína Supressora de Tumor p53 / Compostos Bicíclicos Heterocíclicos com Pontes / Neoplasias de Mama Triplo Negativas / Mutação Limite: Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinuclidinas / Compostos Aza / Proteína Supressora de Tumor p53 / Compostos Bicíclicos Heterocíclicos com Pontes / Neoplasias de Mama Triplo Negativas / Mutação Limite: Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article